Perinatal opioids reduce striatal nerve growth factor content in rat striatum

Citation
Vw. Wu et al., Perinatal opioids reduce striatal nerve growth factor content in rat striatum, EUR J PHARM, 414(2-3), 2001, pp. 211-214
Citations number
25
Categorie Soggetti
Pharmacology & Toxicology
Journal title
EUROPEAN JOURNAL OF PHARMACOLOGY
ISSN journal
00142999 → ACNP
Volume
414
Issue
2-3
Year of publication
2001
Pages
211 - 214
Database
ISI
SICI code
0014-2999(20010302)414:2-3<211:PORSNG>2.0.ZU;2-I
Abstract
Both human and animal models indicate that perinatal methadone exposure pro duces a variety of short- and long-term neurobehavioral consequences, inclu ding disruption of normal development of striatal cholinergic neurons. Desp ite this, methadone maintenance is a standard method of managing pregnant h eroin addicts, and the opioid receptor partial agonist buprenorphine is und er evaluation for the same use. We now report that perinatal administration of either methadone or buprenorphine reduces the content of the neurotroph ic factor nerve growth factor (NGF) in rat striatum, which may explain the behavioral deficits observed. Furthermore, although NGF content is reduced, there are no corresponding reductions in striatal NGF mRNA. (C) 2001 Publi shed by Elsevier Science B.V.